Clinical Trial Update: A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase II study comparing nab-paclitaxel plus cisplatin vs gemcitabine plus cisplatin as first-line therapy for advanced biliary tract cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Biliary Tract Cancer | Phase 2 | Status: UNKNOWN